1. Home
  2. AIRS vs ANIK Comparison

AIRS vs ANIK Comparison

Compare AIRS & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$2.73

Market Cap

169.8M

Sector

Health Care

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$15.58

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
ANIK
Founded
2012
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
191.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
AIRS
ANIK
Price
$2.73
$15.58
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
2.2M
111.6K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
$151,818,000.00
$112,819,000.00
Revenue This Year
$5.30
$5.98
Revenue Next Year
$6.49
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$7.90
52 Week High
$12.00
$15.48

Technical Indicators

Market Signals
Indicator
AIRS
ANIK
Relative Strength Index (RSI) 52.28 66.12
Support Level $2.52 $13.81
Resistance Level $3.36 N/A
Average True Range (ATR) 0.36 0.55
MACD -0.05 -0.04
Stochastic Oscillator 34.78 89.52

Price Performance

Historical Comparison
AIRS
ANIK

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: